The growing burden of misinformation is a complex issue that demands a direct-to-patient channel through trusted sources. By ...

Eli Lilly is expanding its menu of direct-to-consumer healthcare offerings. | Eli Lilly is expanding its menu of ...

Hiring Dalia Rayes as head of commercial for the global efzofitimod franchise slots another piece of the puzzle into place.

Mr. Camiolo brings to TScan demonstrated commercial readiness and cell therapy launch experienceWALTHAM, Mass., March 27, 2025 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a ...

MM+M Agency 100 issue is nominated for Best Single Issue of a Tabloid/Newspaper/Magazine for a brand with revenue between $3 ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (" Quantum BioPharma ” or the " Company ”), is pleased to announce the appointment of Terry Lynch to its board of directors. Mr. Lynch ...

UTC+8Record-Breaking Revenue of HK$553.0M and Net Profit of HK$82.8MFirst-ever Dividend was HK$0.277 Cents Per Share Strengthening Presence in Osteoporosis, Ophthalmology, and Aesthetic Medical ...

Alvotech will conduct a business update conference call and live webcast on Thursday March 27, 2025, at 8:00 am ET (12:00pm ...

Positive results from Phase 3 trial for MaaT013 in acute Graft-versus-Host disease (aGvHD); topline results (January 2025) showed a 62% gastrointestinal overall response rate at Day 28 and 1-year ...

Annual Report/Annual ResultsFormycon reports on a successful financial year 2024 with strong operational progress and continuous strengthening of its market position 27.03.2025 / 06:30 CET/CESTThe ...

FDA Approval of Emrosi (40 mg Minocycline Hydrochloride Modified-Release Capsules) for Rosacea Emrosi Initial Distribution Ongoing; First Prescriptions Filled Total Revenues for the Full Year Ended De ...

The "Cell & Gene Therapies in Gastrointestinal Disorders: Therapeutic Analysis" report has been added to ResearchAndMarkets.com's offering.Both marketed therapies are prescribed when a patient has ...